All lobbying filings

FEROX STRATEGIES

Lobbying for FRESENIUS KABI USA LLC · Generic and biosimilar pharmaceutical manufacturer

Filing Registration

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Mar 18, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Illinois

Official filing document

Lobbyists on this filing 3

CRISTINA ANTELO New on this filing

Previously held: Legal Fellow, Senate Democratic Steering Committee.
MARK WILLIAMS New on this filing

Previously held: Chief of Staff, Rep. Michael Conaway // Chief of Staff, Rep. Todd Rokita // Dep. Chief of Staff/Leg. Director, Rep. Sam Johnson.
MICHAEL TAGGART New on this filing

Previously held: Energy and Commerce Committee --Policy Director; Rep. Cathy McMorris Rodgers -- Legislative Director; Rep. Leonard Lance-- Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 2

Health Issues

Policy and oversight related to generic and biosimilar industry issues.

Pharmacy

Policy and oversight related to generic and biosimilar industry issues.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

FRESENIUS KABI SWISSBIOSIM GMBH

Switzerland · CH - 1262 Eysins · owns 100% of the client · contributed $0.00

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.